Funding programme: Horizon Europe

Call: I3 – 2023 – Cap2b

Project coordinator:AGENTIA PENTRU DEZVOLTARE REGIONALANORD-EST, Romania

Other partners: 

  • North-East Regional Innovative Cluster for Structural and Molecular Imaging, Romania
  • Klaster LifeScience Krakow, Polonia
  • MEDVIA, Belgio
  • Hellenic BioCluster, Grecia
  • Cluster Soluciones Innovadoras para la Vida Independiente SIVI, Spagna
  • Clust-ER Industrie della Salute e del Benessere, Italia
  • Health and Life Sciences Cluster, Bulgaria
  • Health Cluster, Portogallo
  • BIOCAT, Spagna
  • STARTUP MADEIRA, Portogallo
  • InPulse, come centro di trasferimento tecnologico.

Role of EUREGHA: Regional stakeholders engagement

Total budget: € 1 495 046.67 EUREGHA budget: 96 674.49

Starting Date: October 24          Duration: 24 months

The InnoMedCatalyst project is set to revolutionize the 5P medicine ecosystem by boosting the capabilities of various stakeholders to develop, test, and refine digital health solutions. The initiative aims to catalyze open innovation and bridge the gap between MedTech companies and healthcare providers, making Europe a global leader in precision and personalized medicine.

Key objectives include:

  • Mapping Regional Value Chains: We will analyze and visualize the ecosystem of current activities, processes, and stakeholders in 5P digital medicine, resulting in the creation of 10 regional maps that identify key players and their roles.
  • Enhancing Innovation Capacity: The project will facilitate over 25 collaborative activities, including cross-regional workshops, tailored training programs, twinnings, demo days, and learning missions aimed at improving healthcare systems and patient outcomes.
  • Creating an Innovation Ecosystem: By implementing dedicated acceleration and mentorship programs, InnoMedCatalyst will support 36 startups, spinoffs, and entrepreneurs in developing digital medicine solutions.
  • Fostering Open Innovation: Through an Open Innovation Network Platform, we will connect MedTech companies with healthcare providers, allowing for the “test before invest” of 5P medicine solutions, supported by two online B2B brokerage events.
  • Developing Interregional Investment Projects: By 2026, the project aims to generate at least 20 investment-ready projects in precision medicine.

The project is a collaborative effort with a strong focus on the regional level, involving several partners connected with the EUREGHA network: IMAGO-MOL (Associate Member), Clust-ER Emilia Romagna, BioCat Catalonia, and MedVia Flanders

Objectives and Key Activities

  • Work Package 1: Project Management: Coordinating and overseeing project activities to ensure efficient execution within the set timeline and budget.

  • Work Package 2: Regional Value Chain Analysis: Mapping and analyzing regional value chains in digital precision and personalized medicine, engaging stakeholders to build a collaborative ecosystem.

  • Work Package 3: Innovation Capacity and Knowledge Transfer: Organizing best practice workshops and learning visits to strengthen regional innovation and knowledge-sharing efforts.

  • Work Package 5: Roadmaps and Investment Portfolio: Developing strategic roadmaps for regional precision medicine ecosystems and creating a portfolio of investment-ready projects.

  • Work Package 6: Visibility and Dissemination: Enhancing project visibility through effective communication, dissemination of results, and organizing a final conference to promote outcomes.

  • Our Contribution

EUREGHA’s involvement in the InnoMed Catalyst project will leverage our extensive network and expertise in regional healthcare collaboration. Our primary roles include supporting stakeholder engagement, facilitating the dissemination of best practices, and aiding the development and transfer of strategic roadmaps for a stronger precision medicine ecosystem across Europe.